Cocrystal Pharma Announces $40 Million Bought Deal Offering Of Common Stock

Published May 04 2021 at 10:41 PM GMT
Key
Points
  • BOTHELL, Wash., May 04, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc.
  • (Nasdaq: COCP), ("Cocrystal" or the "Company"), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses.




Trending

Stats

  • Published May 4, 2021 10:41 PM GMT